Benjamin L. Palleiko
Net Worth

Last updated:

What is Benjamin L. Palleiko net worth?

The estimated net worth of Mr. Benjamin L. Palleiko is at least $10,430,897 as of 9 Dec 2024. He owns shares worth $3,517,575 as insider, has earned $2,642,222 from insider trading and has received compensation worth at least $4,271,100 in KalVista Pharmaceuticals, Inc..

What is the salary of Benjamin L. Palleiko?

Mr. Benjamin L. Palleiko salary is $711,850 per year as Chief Bus. Officer & Chief Financial Officer in KalVista Pharmaceuticals, Inc..

How old is Benjamin L. Palleiko?

Mr. Benjamin L. Palleiko is 59 years old, born in 1966.

What stocks does Benjamin L. Palleiko currently own?

As insider, Mr. Benjamin L. Palleiko owns shares in one company:

Company Title Shares Price per share Total value
KalVista Pharmaceuticals, Inc. (KALV) Chief Bus. Officer & Chief Financial Officer 274,596 $12.81 $3,517,575

What does KalVista Pharmaceuticals, Inc. do?

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks; KVD824, an oral product candidate for the treatment of HAE; and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. The company is headquartered in Cambridge, Massachusetts.

KALV logo
KALV
KalVista Pharmaceuticals, Inc.
$12.81

Benjamin L. Palleiko insider trading

KalVista Pharmaceuticals, Inc.

Mr. Benjamin L. Palleiko has made 19 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he sold 7,627 units of KALV stock worth $74,363 on 9 Dec 2024.

The largest trade he's ever made was exercising 51,029 units of KALV stock on 17 Feb 2024. As of 9 Dec 2024 he still owns at least 274,596 units of KALV stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 7,627 $9.75 $74,363
Option
Restricted Stock Unit 15,625 N/A N/A
Option
Common Stock 15,625 N/A N/A
Sale
Common Stock 14,400 $9.26 $133,301
Option
Restricted Stock Unit 6,945 N/A N/A
Option
Performance Stock Units 20,834 N/A N/A
Option
Restricted Stock Unit 2,419 N/A N/A
Option
Common Stock 30,198 N/A N/A
Sale
Common Stock 7,352 $12.19 $89,621
Option
Common Stock 15,625 N/A N/A
Option
Restricted Stock Unit 15,625 N/A N/A
Sale
Common Stock 14,215 $12.01 $170,765
Option
Restricted Stock Unit 6,944 N/A N/A
Option
Restricted Stock Unit 2,418 N/A N/A
Option
Performance Stock Units 20,833 N/A N/A
Option
Common Stock 30,195 N/A N/A
Sale
Common Stock 7,465 $11.53 $86,071
Option
Restricted Stock Unit 15,625 N/A N/A
Option
Common Stock 15,625 N/A N/A
Sale
Common Stock 21,959 $11.77 $258,348
Sale
Common Stock 22,802 $14.12 $321,850
Option
Common Stock 51,029 N/A N/A
Option
Restricted Stock Unit 6,944 N/A N/A
Option
Performance Stock Units 20,833 N/A N/A
Option
Restricted Stock Unit 2,419 N/A N/A
Option
Performance Stock Units 20,833 N/A N/A
Sale
Common Stock 40,855 $15.01 $613,193
Sale
Common Stock 13,008 $8.23 $107,043
Option
Performance Stock Unit 20,833 N/A N/A
Option
Restricted Stock Unit 6,945 N/A N/A
Option
Common Stock 30,197 N/A N/A
Option
Restricted Stock Unit 2,419 N/A N/A
Sale
Common Stock 13,067 $10.73 $140,196
Option
Performance Stock Unit 20,833 N/A N/A
Option
Restricted Stock Unit 6,944 N/A N/A
Option
Common Stock 30,195 N/A N/A
Option
Restricted Stock Unit 2,418 N/A N/A
Sale
Common Stock 4,037 $10.14 $40,951
Option
Common Stock 9,364 N/A N/A
Option
Restricted Stock Unit 2,419 N/A N/A
Option
Restricted Stock Unit 6,945 N/A N/A
Option
Restricted Stock Unit 2,419 N/A N/A
Sale
Common Stock 4,954 $7.66 $37,948
Option
Common Stock 9,363 N/A N/A
Option
Performance Restricted Stock Unit 6,944 N/A N/A
Sale
Common Stock 722 $5.44 $3,928
Option
Restricted Stock Unit 2,419 N/A N/A
Option
Common Stock 2,419 N/A N/A
Option
Restricted Stock Unit 2,418 N/A N/A
Sale
Common Stock 725 $14.96 $10,847
Option
Common Stock 2,418 N/A N/A
Option
Employee Stock Option (right to buy) 29,642 N/A N/A
Sale
Common Stock 29,642 $16.7 $494,962
Sale
Common Stock 29,642 N/A N/A
Option
Common Stock 29,642 N/A N/A
Sale
Common Stock 358 N/A N/A
Option
Employee Stock Option (right to buy) 358 N/A N/A
Option
Common Stock 358 N/A N/A
Sale
Common Stock 2,000 $25.8 $51,604
Option
Employee Stock Option (Right to Buy) 2,000 $25.8 $51,604
Option
Common Stock 2,000 $25.8 $51,604
Option
Common Stock 1,073 $6.74 $7,232
Sale
Common Stock 1,073 $6.74 $7,232
Option
Employee Stock Option (Right to Buy) 1,073 $6.74 $7,232

KalVista Pharmaceuticals key executives

KalVista Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: